The article discusses a research paper on the development of T cells with a T cell receptor specific for prostate antigen TARP. It references a study by V. Hillerdal et al., published in a 2012 issue of the "Proceedings of the National Academy of Sciences of the United States of America". The study shows that prostate cancer cells expressing TARP were killed.